Optimal number of accrual groups and accrual group sizes in longitudinal trials with discrete-time survival endpoints

Maryam Safarkhani, Shahab Jolani*, Mirjam Moerbeek

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

In longitudinal trials, the number of accrual groups and their sizes should carefully be chosen to ensure a desired power to detect a specified treatment effect. Methods are proposed to obtain a cost-effective combination of the number and size of accrual groups that provides high efficiency at minimal cost. We focus on trials where an event occurs at any point in time, but it is recorded on a discrete scale. The Weibull survival function is considered for modeling the underlying time to event. By using a cost function, it is shown that the ratio of the cost of recruiting and treating subjects to the cost of measuring them and also the survival pattern highly influence the optimal combination of the number and size of accrual groups. A maximin approach is further presented to obtain robust designs with respect to poor specification of these modeling parameters. We also show the application of the proposed optimal design methodology using real examples.

Original languageEnglish
Pages (from-to)43-60
Number of pages18
JournalStatistica Neerlandica
Volume68
Issue number1
DOIs
Publication statusPublished - 1 Feb 2014

Keywords

  • Discrete-time survival analysis
  • Locally optimal design
  • Longitudinal trial with accrual groups
  • Maximin design
  • Treatment effect size

Fingerprint

Dive into the research topics of 'Optimal number of accrual groups and accrual group sizes in longitudinal trials with discrete-time survival endpoints'. Together they form a unique fingerprint.

Cite this